Company Neuland Laboratories Limited

Equities

NEULANDLAB

INE794A01010

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:53 2024-07-12 am EDT 5-day change 1st Jan Change
8,095 INR -0.05% Intraday chart for Neuland Laboratories Limited +4.24% +53.10%

Business Summary

Neuland Laboratories Limited is an India-based company. The Company is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The Company is an active pharmaceutical ingredient (API) manufacturing and development organization that caters to the pharmaceutical and biotech industry’s chemistry needs. It provides solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying New Chemical Entities (NCEs) and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its key molecules include Mirtazapine, an anti-depressant and Levetiracetam, an anti-epileptic agent. The Company’s product portfolio includes over 100 APIs across 10 diverse therapeutic areas.

Number of employees: 1,643

Sales per Business

INR in Million2023Weight2024Weight Delta
Active Pharmaceutical Ingredients and Allied Services
100.0 %
11,912 100.0 % 15,586 100.0 % +30.84%

Sales per region

INR in Million2023Weight2024Weight Delta
North America
54.0 %
6,075 51.0 % 8,416 54.0 % +38.54%
Europe
35.0 %
3,931 33.0 % 5,455 35.0 % +38.77%
Japan
4.0 %
357 3.0 % 623 4.0 % +74.46%
Latin America
3.0 %
476 4.0 % 468 3.0 % -1.87%
APAC
2.0 %
596 5.0 % 312 2.0 % -47.66%
India
1.0 %
119 1.0 % 156 1.0 % +30.84%
Middle East and North Africa
1.0 %
357 3.0 % 156 1.0 % -56.39%

Managers

Managers TitleAgeSince
Chief Executive Officer 48 01-12-31
Director of Finance/CFO - 22-11-22
Chief Tech/Sci/R&D Officer - Nov. 21
Compliance Officer - 12-01-02
Director/Board Member 44 07-02-28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 78 22-10-30
Director/Board Member 80 19-02-11
Director/Board Member 60 23-06-26
Chief Executive Officer 48 01-12-31
Founder 80 84-01-06
Director/Board Member 80 09-10-19
Director/Board Member 44 07-02-28
Director/Board Member 55 23-06-26
Director/Board Member 78 15-05-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,829,889 7,996,721 ( 62.33 %) 0 62.33 %

Shareholders

NameEquities%Valuation
2,769,974 21.59 % 249 M ₹
Malabar Investments LLC
12.64 %
1,621,782 12.64 % 146 M ₹
613,338 4.781 % 55 M ₹
Matthews International Capital Management LLC
4.071 %
522,353 4.071 % 47 M ₹
400,000 3.118 % 36 M ₹
HSBC Asset Management (India) Pvt Ltd.
2.715 %
348,322 2.715 % 31 M ₹
337,542 2.631 % 30 M ₹
287,087 2.238 % 26 M ₹
quant Money Managers Ltd.
1.497 %
192,067 1.497 % 17 M ₹
Ocean Dial Asset Management Ltd.
1.332 %
170,888 1.332 % 15 M ₹

Company contact information

Neuland Laboratories Ltd.

Phoenix IVY Building Plot No.573A-III, Road No. 82

500033, Hyderabad

+91 40 6761 1600

http://www.neulandlabs.com
address Neuland Laboratories Limited(NEULANDLAB)

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8,095 INR
Average target price
8,300 INR
Spread / Average Target
+2.53%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NEULANDLAB Stock
  4. Company Neuland Laboratories Limited